Summary

On July 22, 2026, the European Food Safety Authority established an acceptable daily intake of 0.014 mg/kg body weight per day and an acute reference dose of 0.07 mg/kg body weight for trifluoroacetic acid, both expressed as TFA. The previous ADI of 0.05 mg/kg body weight per day was expressed as sodium trifluoroacetate, or TFA Na, so the old and new numerical values should not be transferred into exposure models without checking their chemical basis. The revised values do not automatically change food limits, drinking-water parameters, pesticide authorisations, or commercial specifications. Food, water, and pesticide teams should first requalify analyte identity, reporting basis, analytical scope, sampling coverage, exposure assumptions, and source evidence. The main risk is not merely using old data—it is using technically valid data for a decision that the original method and sampling design were not intended to support.

The News in Brief

EFSA published its scientific report on consumer health-based guidance values for TFA on July 22, 2026.

The report established:

• an ADI of 0.014 mg/kg body weight per day, expressed as TFA;
• an ARfD of 0.07 mg/kg body weight, expressed as TFA;
• a conclusion that TFA and TFA Na are unlikely to be genotoxic;
• additional uncertainty related to the absence of a complete long-term carcinogenicity study and limitations in developmental immunotoxicity evidence.

Reduced thyroxine levels observed in animal evidence were used as the critical basis for deriving the new health-based guidance values. The ADI addresses long-term daily exposure, while the ARfD addresses exposure over one day or less.

These are toxicological reference values used in risk assessment. They are not food specifications, raw-material limits, drinking-water concentration limits, or automatic product-release criteria.

The Old and New ADIs Use Different Chemical Bases

The previous ADI was 0.05 mg/kg body weight per day expressed as TFA Na. The revised ADI is 0.014 mg/kg body weight per day expressed as TFA.

EFSA applied a conversion factor of 0.84 when adjusting between TFA Na and TFA to account for their different relative molecular masses. The scientific report also expresses the new ARfD as TFA.

This creates an important data-control requirement:

An exposure value expressed as TFA Na should not be compared with a limit expressed as TFA until the reporting basis and conversion have been confirmed.

Historical calculations should therefore record:

• whether concentrations were expressed as TFA or TFA Na;
• whether salts were converted to the acid basis;
• which molecular-weight conversion was applied;
• whether the same basis was used for occurrence data, exposure inputs, and the toxicological reference value.

A numerical comparison that ignores chemical basis may produce an incorrect exposure ratio even when every individual number was accurately reported.

Confirmed Milestones and Current Status

The EFSA report does not itself:

• amend pesticide maximum residue levels;
• cancel or restrict a pesticide authorisation;
• create a TFA-specific food limit;
• replace EU drinking-water parametric values;
• require TFA testing on every commercial batch;
• prove that detected TFA came from a particular source.

Changes to legal limits, authorisations, monitoring requirements, or market controls require separate risk-management decisions.

Which Existing Data Need Requalification?

The lower ADI does not make every historical result unusable. Each dataset should instead be classified according to the decision it can legitimately support.

The decisive question is not whether data are recent. It is whether the analyte, chemical basis, matrix, analytical window, sampling design, and reporting convention match the decision now being made.

Food Monitoring Should Start with the Reporting Basis

A report labelled “PFAS analysis” does not establish that TFA was measured.

Food producers, quality teams, and contract laboratories should verify:

• exact analyte identity;
• TFA versus TFA Na reporting basis;
• sample matrix and preparation procedure;
• method-validation scope;
• limit of quantification;
• recovery and matrix effects;
• treatment of non-detect results;
• raw versus processed food status;
• geographic and seasonal representation;
• suitability for acute or chronic exposure assessment.

A method validated in drinking water should not automatically be treated as validated for high-fat, high-protein, acidic, or highly processed food.

Chronic exposure assessment requires representative long-term occurrence and consumption data. Acute assessment may depend more strongly on individual commodity concentrations, high-consumption portions, and upper-end results. The two assessments should not automatically use the same sampling design or statistical treatment.

Drinking-Water Data Require Three Separate Questions

Which Regulatory Parameter Applies?

Directive (EU) 2020/2184 defines both PFAS Total and Sum of PFAS. Member States may decide to use either one or both in national implementation. The two parameters should therefore not be presented as though every EU jurisdiction applies them in exactly the same way.

The national legal basis and applicable parameter should be confirmed before interpreting a result as compliant or non-compliant.

Does the Sum of PFAS Include TFA?

No.

The Sum of PFAS parameter covers 20 specified substances with defined structural and chain-length characteristics. TFA is an ultrashort-chain PFAS and is excluded from that list.

A compliant Sum of PFAS result therefore does not demonstrate that the TFA concentration is low.

How Was PFAS Total Estimated?

PFAS Total is a regulatory parameter, not the name of one complete analytical method.

The European Commission’s technical guidelines for PFAS monitoring in drinking water state that no single analytical method can fully quantify the entire PFAS class. The recommended approaches therefore use proxy methods such as:

• total oxidisable precursor assay;
• extractable organic fluorine with combustion ion chromatography;
• LC-HRMS suspect and non-target analysis.

Each method has a different analytical window and should be identified in the report. A result should not be presented simply as “PFAS Total” without indicating how it was generated.

The Commission’s recommended reporting approach is to:

1. determine a PFAS Total proxy result using an identified method;
2. determine TFA separately using a targeted analytical method;
3. report the PFAS Total result, the TFA result, and PFAS Total minus TFA;
4. mark the outcome as inconclusive if the subtraction produces a negative result.

This hierarchy keeps three different elements separate:

regulatory parameter → proxy analytical method → targeted TFA result.

For environmental monitoring projects, suitable agricultural and environmental analytical standards should be selected by analyte, matrix, intended method, certified value, uncertainty, and decision purpose—not by a broad PFAS description alone.

Pesticide Data Must Extend Beyond the Batch COA

Certain fluorinated pesticide active substances may form TFA through degradation, but the assessment must remain substance- and use-specific.

A commercial COA may support:

• active-substance identity;
• assay or purity;
• specified impurity control;
• release against an agreed commercial specification.

It does not normally establish:

• the proportion that may degrade to TFA;
• formation under different soils or climates;
• uptake into primary or rotational crops;
• movement into groundwater or surface water;
• contribution to drinking-water exposure;
• combined exposure from multiple uses.

Registrants and regulatory teams may need to reconnect the commercial product record with degradation studies, crop metabolism, environmental fate, field monitoring, application patterns, water modelling, and dietary exposure assumptions.

The presence of fluorine in a molecular structure is not sufficient evidence of a specific TFA formation rate.

Where parent compounds or relevant metabolites require analytical verification, pesticide residue reference standards should be matched to the residue definition and intended analytical decision. A standard for the parent active substance cannot substitute for targeted TFA measurement.

Method Qualification, Pilot Monitoring, and Routine Decisions Are Not Equivalent

A successful method-development sample demonstrates only that the analytical approach worked under the tested conditions.

A pilot monitoring program can show that sampling, transport, preparation, and analysis are feasible at selected sites or in selected matrices.

Routine regulatory or commercial decisions require more:

• representative sampling;
• stable method performance;
• traceable sample and batch identity;
• consistent reporting conventions;
• documented laboratory and method changes;
• defined treatment of non-detect results;
• evidence that the matrix and concentration range remain within scope.

A pilot result may justify broader monitoring. It does not automatically support market approval, source attribution, supplier rejection, or a permanent specification change.

The Immediate Risk Is Using Valid Data for the Wrong Decision

Most discussion will focus on the lower ADI. The more immediate operational risk is data being promoted beyond the purpose for which it was generated.

Three boundaries should remain clear.

Detection Is Not Exposure

A measured concentration confirms occurrence in a specific sample. It does not establish chronic intake, acute exposure, or risk without consumption and body-weight assumptions.

Occurrence Is Not Source Attribution

A TFA result does not identify whether the source was a pesticide, refrigerant, industrial activity, wastewater, atmospheric transport, or another precursor pathway.

Parameter Compliance Is Not TFA Data Completeness

A water result can comply with the Sum of PFAS parameter while providing no direct TFA information. A pesticide batch can meet its commercial specification while environmental TFA formation remains a separate assessment question.

The practical response is to classify each dataset as supporting one of six tasks:

screening, occurrence monitoring, exposure assessment, legal compliance, product release, or source attribution.

Data generated for one task should not be used for another until method scope, sampling design, chemical basis, traceability, and uncertainty have been reviewed.

Immediate Action Order

Begin by separating:

• TFA results from generic PFAS results;
• TFA-basis values from TFA Na-basis values;
• Sum of PFAS results from PFAS Total proxy results;
• occurrence data from exposure calculations;
• product-release evidence from environmental fate evidence;
• source hypotheses from source-attribution evidence.

Next, classify each dataset as:

• suitable without change;
• suitable after conversion or recalculation;
• suitable only for screening;
• requiring additional targeted analysis;
• unsuitable for the intended decision.

A specification, supplier status, monitoring plan, or regulatory conclusion should not be changed until the underlying data have a confirmed analyte, chemical basis, matrix, analytical method, sampling period, and decision purpose.

What to Watch Next

The next relevant developments will be formal scientific or regulatory actions, including:

• pesticide assessments applying the revised ADI and ARfD;
• decisions on residue definitions or exposure models;
• national implementation of drinking-water PFAS parameters;
• new TFA occurrence data for food and water;
• improved comparability among targeted and proxy methods;
• additional long-term and developmental toxicity evidence.

Until these steps are completed, the defensible action is to identify data gaps and correct incompatible reporting bases rather than assume immediate changes to every fluorinated material or commercial specification.

For a TFA-related analytical project, provide the target analyte, chemical basis, matrix, analytical method, intended decision, concentration range, sample quantity, target market, and documentation requirements. ChemicalCell can review whether relevant analytical materials and supporting documents are available for the defined testing purpose.